Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Merck gains FDA priority review for sotatercept BLA
Merck filed BLA for sotatercept based on findings from the Phase III STELLAR clinical trial in pulmonary arterial hypertension patients. Credit: Yale Rosen from USA / commons.wikimedia.org.
Merck filed BLA for sotatercept based on findings from the Phase III STELLAR clinical trial in pulmonary arterial hypertension patients. Credit: Yale Rosen from USA / commons.wikimedia.org.